Metabolomics and biomarker discovery: NMR spectral data of urine and hepatotoxicity by carbon tetrachloride, acetaminophen, and d-galactosamine in rats

Metabolomics

Volumn 4, Issue 4, 2008, Pages 377-392

  Kim, Kyu Bong ^a   Chung, Myeon Woo ^a   Um, So Young ^a   Oh, Ji Seon ^a   Kim, Seon Hwa ^a   Na, Mi Ae ^a   Oh, Hye Young ^a   Cho, Wan Seob ^a   Choi, Ki Hwan ^a  

^a Korea Food and Drug Administration   (South Korea)

Author keywords

Acetaminophen; Biomarkers; CCl4; Hepatotoxicity; Metabolomics; NMR

Indexed keywords

ANIMALIA; RATTUS;

EID: 55349132683     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-008-0131-5     Document Type: Article

References (51)

1. Andringa, K. K., Bajt, M. L., Jaeschke, H., & Bailey, S. M. (2008). Mitochondrial protein thiol modifications in acetaminophen hepatotoxicity: Effect on HMG-CoA synthase. Toxicology Letters, 177, 188-197. doi: 10.1016/j.toxlet.2008.01.010.
2. Ayonrinde, O. T., Phelps, G. J., Hurley, J. C., & Ayonrinde, O. A. (2005). Paracetamol overdose and hepatotoxicity at a regional Australian hospital: A 4-year experience. Internal Medicine Journal, 35, 655-660. doi: 10.1111/j.1445-5994.2005.00947.x.
3. Beckwith-Hall, B. M., Nicholson, J. K., Nicholls, A. W., Foxall, P. J., Lindon, J. C., Connor, S. C., et al. (1998). Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chemical Research in Toxicology, 11, 260-272. doi: 10.1021/tx9700679.
4. Biour, M., Poupon, R., Grange, J. D., Chazouilleres, O., & Jaillon, P. (1998). Drug-induced hepatotoxicity. Eleventh update of the bibliographic database on liver injuries and responsible drugs. Gastroenterologie Clinique et Biologique, 22, 1004-1044.
5. Caldwell, G. W., Ritchie, D. M., Masucci, J. A., Hageman, W., & Yan, Z. (2001). The new pre-preclinical paradigm: Compound optimization in early and late phase drug discovery. Current Topics in Medicinal Chemistry, 1, 353-366. doi: 10.2174/1568026013394949.
6. Cavaluzzi, M. J., Kerwood, D. J., & Borer, P. N. (2002). Accurate nucleic acid concentrations by nuclear magnetic resonance. Analytical Biochemistry, 308, 373-380. doi: 10.1016/S0003-2697(02)00262-2.
7. Chadha, V., Garg, U., & Alon, U. S. (2001). Measurement of urinary concentration: A critical appraisal of methodologies. Pediatric Nephrology (Berlin, Germany), 16, 374-382. doi: 10.1007/s004670000551.
8. Clayton, T. A., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., et al. (2006). Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature, 440, 1073-1077. doi: 10.1038/ nature04648.
9. Coen, M., O'Sullivan, M., Bubb, W. A., Kuchel, P. W., & Sorrell, T. (2005). Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clinical Infectious Diseases, 41, 1582-1590. doi: 10.1086/497836.
10. Constantinou, M. A., Theocharis, S. E., & Mikros, E. (2007). Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Toxicology and Applied Pharmacology, 218, 11-19. doi: 10.1016/j.taap.2006.10.007.
11. Craig, A., Sidaway, J., Holmes, E., Orton, T., Jackson, D., Rowlinson, R., et al. (2006). Systems toxicology: Integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. Journal of Proteome Research, 5, 1586-1601. doi: 10.1021/pr0503376.
12. Crockford, D. J., Keun, H. C., Smith, L. M., Holmes, E., & Nicholson, J. K. (2005). Curve-fitting method for direct quantitation of compounds in complex biological mixtures using 1 H NMR: Application in metabonomic toxicology studies. Analytical Chemistry, 77, 4556-4562. doi: 10.1021/ac0503456.
13. Cuatrecasas, P. (2006). Drug discovery in jeopardy. The Journal of Clinical Investigation, 116, 2837-2842. doi: 10.1172/JCI29999.
14. Duarte, I. F., Stanley, E. G., Holmes, E., Lindon, J. C., Gil, A. M., Tang, H., et al. (2005). Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1 H NMR spectroscopy. Analytical Chemistry, 77, 5570-5578. doi: 10.1021/ac050455c.
15. Dunn, W. B., Bailey, N. J., & Johnson, H. E. (2005). Measuring the metabolome: Current analytical technologies. Analyst (London), 130, 606-625. doi: 10.1039/b418288j.
16. Ekins, S., Nikolsky, Y., & Nikolskaya, T. (2005). Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends in Pharmacological Sciences, 26, 202-209. doi: 10.1016/j.tips.2005.02.006.
17. Fontana, R. J., & Quallich, L. G. (2001). Acute liver failure. Current Opinion in Gastroenterology, 17, 291-298. doi: 10.1097/ 00001574-200105000-00013.
18. Fukushima, T., Kikkawa, R., Hamada, Y., & Horii, I. (2006). Genomic cluster and network analysis for predictive screening for hepatotoxicity. The Journal of Toxicological Sciences, 31, 419-432. doi: 10.2131/jts.31.419.
19. Fung, M., Thornton, A., Mybeck, K., Wu, J. H., Hornbuckle, K., & Muniz, E. (2001). Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999. Drug Information Journal, 35, 293-317.
20. Gatley, S. J., & Sherratt, H. S. (1977). The synthesis of hippurate from benzoate and glycine by rat liver mitochondria. Submitochondrial localization and kinetics. The Biochemical Journal, 166, 39-47.
21. Gavaghan, C. L., Wilson, I. D., & Nicholson, J. K. (2002). Physiological variation in metabolic phenotyping and functional genomic studies: Use of orthogonal signal correction and PLS-DA. FEBS Letters, 530, 191-196. doi: 10.1016/S0014-5793(02)03476-2.
22. Griffin, J. L., Scott, J., & Nicholson, J. K. (2007). The influence of pharmacogenetics on fatty liver disease in the wistar and kyoto rats: A combined transcriptomic and metabonomic study. Journal of Proteome Research, 6, 54-61. doi: 10.1021/pr0601640.
23. Holmes, E., Nicholls, A. W., Lindon, J. C., Ramos, S., Spraul, M., Neidig, P., et al. (1998). Development of a model for classification of toxin-induced lesions using 1 H NMR spectroscopy of urine combined with pattern recognition. NMR in Biomedicine, 11, 235-244. doi:10.1002/ (SICI)1099-1492(199806/08)11:4/5<235::AID-NBM507>3.0.CO;2-V.
24. Kaplowitz, N. (2001). Drug-induced liver disorders: Implications for drug development and regulation. Drug Safety, 24, 483-490. doi: 10.2165/ 00002018-200124070-00001.
25. Keller, N. P., Turner, G., & Bennett, J. W. (2005). Fungal secondary metabolism-from biochemistry to genomics. Nature Reviews Microbiology, 3, 937-947. doi: 10.1038/nrmicro1286.
26. Keun, H. C., Ebbels, T. M., Antti, H., Bollard, M. E., Beckonert, O., Schlotterbeck, G., et al. (2002). Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. Chemical Research in Toxicology, 15, 1380-1386. doi: 10.1021/tx0255774.
27. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., et al. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (Baltimore, Md.), 1, 431-435. doi: 10.1002/hep.1840010511.
28. Kuwahata, M., Tomoe, Y., Harada, N., Amano, S., Segawa, H., Tatsumi, S., et al. (2007). Characterization of the molecular mechanisms involved in the increased insulin secretion in rats with acute liver failure. Biochimica et Biophysica Acta, 1772, 60-65.
29. Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., & Nicholson, J. K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 9, 1-31. doi: 10.1080/ 13547500410001668379.
30. Llinares Tello, F., Hernandez Prats, C., Bosacoma Ros, N., Perez Martinez, E., Climent Grana, E., Navarro Polo, J. N., et al. (2005). Acute cholestatic hepatitis probably associated with risperidone. International Journal of Psychiatry in Medicine, 35, 199-205. doi: 10.2190/5XRB-D2XX-X8AH-32KB.
31. Megli, F. M., & Sabatini, K. (2004). Mitochondrial phospholipid bilayer structure is ruined after liver oxidative injury in vivo. FEBS Letters, 573, 68-72. doi: 10.1016/j.febslet.2004.07.057.
32. Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181-1189. doi: 10.1080/004982599238047.
33. Petterino, C., & Argentino-Storino, A. (2006). Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Experimental and Toxicologic Pathology, 57, 213-219. doi: 10.1016/j.etp.2005.10.002.
34. Rastall, R. A., Gibson, G. R., Gill, H. S., Guarner, F., Klaenhammer, T. R., Pot, B., et al. (2005). Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: An overview of enabling science and potential applications. FEMS Microbiology Ecology, 52, 145-152. doi: 10.1016/j.femsec.2005.01.003.
35. Robertson, D. G., Reily, M. D., & Baker, J. D. (2005). Metabonomics in preclinical drug development. Expert Opinion on Drug Metabolism & Toxicology, 1, 363-376. doi: 10.1517/17425255.1.3.363.
36. Robertson, D. G., Reily, M. D., Sigler, R. E., Wells, D. F., Paterson, D. A., & Braden, T. K. (2000). Metabonomics: Evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicological Sciences, 57, 326-337. doi: 10.1093/toxsci/57.2.326.
37. Sanins, S. M., Nicholson, J. K., Elcombe, C., & Timbrell, J. A. (1990). Hepatotoxin-induced hypertaurinuria: A proton NMR study. Archives of Toxicology, 64, 407-411. doi: 10.1007/BF01973464.
38. Schnackenberg, L. K., Dragan, Y. P., Reily, M. D., Robertson, D. G., & Beger, R. D. (2007). Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants. Metabolomics, 3, 87-100. doi: 10.1007/s11306-006-0046-y.
39. Schoonen, W. G., Kloks, C. P., Ploemen, J. P., Horbach, G. J., Smit, M. J., Zandberg, P., et al. (2007). Sensitivity of (1)H NMR analysis of rat urine in relation to toxicometabonomics. Part I: Dose-dependent toxic effects of bromobenzene and paracetamol. Toxicological Sciences, 98, 271-285. doi: 10.1093/toxsci/kfm076.
40. Schuster, M. A., McGlynn, E. A., & Brook, R. H. (2005). How good is the quality of health care in the United States? 1998. The Milbank Quarterly, 83, 843-895. doi: 10.1111/j.1468-0009.2005.00403.x.
41. Smith, D. A., & Schmid, E. F. (2006). Drug withdrawals and the lessons within. Current Opinion in Drug Discovery & Development, 9, 38-46.
42. Sprague, G. F., Cullen, P. J., & Goehring, A. S. (2004). Yeast signal transduction: Regulation and interface with cell biology. Advances in Experimental Medicine and Biology, 547, 91-105.
43. Stoyanova, R., & Brown, T. R. (2001). NMR spectral quantitation by principal component analysis. NMR in Biomedicine, 14, 271-277. doi: 10.1002/nbm.700.
44. Sun, J., Schnackenberg, L. K., Holland, R. D., Schmitt, T. C., Cantor, G. H., Dragan, Y. P., & Beger, R. D. (2008). Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. Journal of Chromatography B. doi: 10.1016/ j.jchromb2008.04.008.
45. Tate, A. R., Damment, S. J., & Lindon, J. C. (2001). Investigation of the metabolite variation in control rat urine using (1)H NMR spectroscopy. Analytical Biochemistry, 291, 17-26. doi: 10.1006/ abio.2001.5008.
46. Vickers, A. E., & Fisher, R. L. (2004). Organ slices for the evaluation of human drug toxicity. Chemico-Biological Interactions, 150, 87-96. doi: 10.1016/j.cbi.2004.09.005.
47. Waters, N. J., Holmes, E., Williams, A., Waterfield, C. J., Farrant, R. D., & Nicholson, J. K. (2001). NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: An integrative metabonomic approach. Chemical Research in Toxicology, 14, 1401-1412. doi: 10.1021/ tx010067f.
48. Wills, P. J., Suresh, V., Arun, M., & Asha, V. V. (2006). Antiangiogenic effect of Lygodium flexuosum against N -nitrosodiethylamine-induced hepatotoxicity in rats. Chemico-Biological Interactions, 164, 25-38. doi: 10.1016/j.cbi.2006.08.021.
49. Wilson, I. D., Plumb, R., Granger, J., Major, H., Williams, R., & Lenz, E. M. (2005). HPLC-MS-based methods for the study of metabonomics. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 817, 67-76. doi: 10.1016/j.jchromb.2004.07.045.
50. Xu, J., & Purcell, W. M. (2006). Energy metabolism and biotransformation as endpoints to pre-screen hepatotoxicity using a liver spheroid model. Toxicology and Applied Pharmacology, 216, 293-302.
51. Yavuz, A., Tetta, C., Ersoy, F. F., D'intini, V., Ratanarat, R., De Cal, M., et al. (2005). Uremic toxins: A new focus on an old subject. Seminars in Dialysis, 18, 203-211. doi: 10.1111/j.1525-139X.2005.18313.x.